首页 > 最新文献

Journal of thoracic disease最新文献

英文 中文
Efficacy, safety and patient satisfaction of two-stage versus single-stage computed tomography guided localization and resection of pulmonary nodules. 两阶段与单阶段计算机断层扫描引导的肺结节定位和切除术的疗效、安全性和患者满意度对比。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-11 DOI: 10.21037/jtd-24-303
Hei Yu Matthew Chen, Tsz Ho Andrew Wong, Ki Kwong Li, Ho Yan Howard Chan

Background: Low-dose computed tomography (CT) has been increasingly utilized for lung cancer screening. Localization of solitary pulmonary nodules (SPN) is crucial for resection. Two-stage localization method involves dye injection by radiologists prior to the operation. The significant interval between localization and resection is associated with a higher risk of marker failure, psychological distress and procedural complications. Single-stage localization and resection procedure under general anesthesia poses unique challenges. The aim of the study is to compare the safety, efficacy and patient satisfaction between the two methods.

Methods: This is a retrospective study comparing outcomes between two-stage and single-stage pre-operative localization of SPN. The primary study outcome was total operating time. Secondary outcomes included successful lesion localization, complication rate, 30-day readmission, mortality, patient satisfaction, and pain level.

Results: A total of 26 and 56 patients were included for the single and two-stage group respectively. Total operative time was significantly longer in the single-stage arm (mean: 188 min) than that of the two-stage arm (mean: 172 min, P<0.001) due to the additional time needed for intra-operative localization. Mean satisfaction score was significantly higher in the single-stage group than that of the two-stage group (92 vs. 52.69, P=0.004). Pain level assessed by numerical rating scales was better in the single-stage arm compared to the two-stage arm (mean: 8.8 vs. 4.85, P=0.007).

Conclusions: Single-stage localization and resection resulted in a minor increase in total operative time, higher patient satisfaction and less pain with comparable safety and efficacy to conventional two-stage approach.

背景:低剂量计算机断层扫描(CT)越来越多地被用于肺癌筛查。单发肺结节(SPN)的定位对切除手术至关重要。两阶段定位法包括放射科医生在手术前注射染料。定位与切除之间的间隔时间较长,导致标记失败、心理困扰和手术并发症的风险较高。在全身麻醉下进行单阶段定位和切除手术具有独特的挑战性。本研究旨在比较两种方法的安全性、有效性和患者满意度:这是一项回顾性研究,比较了两阶段和单阶段 SPN 术前定位的结果。主要研究结果是总手术时间。次要结果包括病灶定位成功率、并发症发生率、30 天再入院率、死亡率、患者满意度和疼痛程度:单阶段组和双阶段组分别共有 26 名和 56 名患者。单级手术组的总手术时间(平均:188 分钟)明显长于两级手术组(平均:172 分钟,Pvs.52.69,P=0.004)。通过数字评分量表评估的疼痛程度,单阶段手术组优于双阶段手术组(平均:8.8 vs. 4.85,P=0.007):单阶段定位和切除术略微延长了总手术时间,提高了患者满意度,减轻了疼痛,其安全性和有效性与传统的两阶段方法相当。
{"title":"Efficacy, safety and patient satisfaction of two-stage versus single-stage computed tomography guided localization and resection of pulmonary nodules.","authors":"Hei Yu Matthew Chen, Tsz Ho Andrew Wong, Ki Kwong Li, Ho Yan Howard Chan","doi":"10.21037/jtd-24-303","DOIUrl":"10.21037/jtd-24-303","url":null,"abstract":"<p><strong>Background: </strong>Low-dose computed tomography (CT) has been increasingly utilized for lung cancer screening. Localization of solitary pulmonary nodules (SPN) is crucial for resection. Two-stage localization method involves dye injection by radiologists prior to the operation. The significant interval between localization and resection is associated with a higher risk of marker failure, psychological distress and procedural complications. Single-stage localization and resection procedure under general anesthesia poses unique challenges. The aim of the study is to compare the safety, efficacy and patient satisfaction between the two methods.</p><p><strong>Methods: </strong>This is a retrospective study comparing outcomes between two-stage and single-stage pre-operative localization of SPN. The primary study outcome was total operating time. Secondary outcomes included successful lesion localization, complication rate, 30-day readmission, mortality, patient satisfaction, and pain level.</p><p><strong>Results: </strong>A total of 26 and 56 patients were included for the single and two-stage group respectively. Total operative time was significantly longer in the single-stage arm (mean: 188 min) than that of the two-stage arm (mean: 172 min, P<0.001) due to the additional time needed for intra-operative localization. Mean satisfaction score was significantly higher in the single-stage group than that of the two-stage group (92 <i>vs.</i> 52.69, P=0.004). Pain level assessed by numerical rating scales was better in the single-stage arm compared to the two-stage arm (mean: 8.8 <i>vs.</i> 4.85, P=0.007).</p><p><strong>Conclusions: </strong>Single-stage localization and resection resulted in a minor increase in total operative time, higher patient satisfaction and less pain with comparable safety and efficacy to conventional two-stage approach.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomical partial lobectomy-encouraging initial experiences of a novel approach to sublobar resection. 解剖性肺叶部分切除术--鼓舞人心的肺叶下切除术新方法的初步经验。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-10 DOI: 10.21037/jtd-24-504
Max Fend, Ben Shanahan
{"title":"Anatomical partial lobectomy-encouraging initial experiences of a novel approach to sublobar resection.","authors":"Max Fend, Ben Shanahan","doi":"10.21037/jtd-24-504","DOIUrl":"10.21037/jtd-24-504","url":null,"abstract":"","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the impact of electrocardiographic parameters on the risk of common arrhythmias: a two-sample Mendelian randomization study. 探索心电图参数对常见心律失常风险的影响:双样本孟德尔随机研究。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-26 DOI: 10.21037/jtd-24-814
Guangheng Wu, Qiaoyun Zhang, Jie Zhang, Jinqi Zhu, Deqiang Zheng, Youxin Wang, Lijuan Wu

Background: Observational studies have shown that heart rate (HR), heart rate variability (HRV), P-wave terminal force, P-wave duration, T-wave amplitude and PR interval are associated with risk factors for atrial fibrillation (AF) or bradycardia. Arrhythmias are associated with many causes of hospitalization. However, observational studies are susceptible to confounding factors that have not yet been identified. The objective of this study was to clarify the causal relationships by Mendelian randomization analysis.

Methods: We conducted a two-sample and multivariate Mendelian randomization (MVMR) analysis using genome-wide association study (GWAS) data from a European population to assess the total and direct causal effects of HR, three HRV traits, P-wave terminal force, P-wave duration, T-wave top amplitude in five-lead modes, and the PR interval on the risk of AF (N=191,205), bradycardia (N=463,010), and supraventricular tachycardia (SVT) (N=463,010).

Results: The results of the univariate MR analysis revealed the following significant causal effects: the higher the genetically predicted PR interval, the lower the risk of AF; the higher the HR and T-wave top amplitude (aVR leads and V3 + V4 + aVL leads), the lower the risk of bradycardia; and the higher HR and the lower PR interval, the higher the risk of SVT. The multivariate MR results indicated that the HRV_standard deviation of the normal-to-normal (SDNN) interval had an independent causal effect on the risk of AF [odds ratio (OR): 0.515; 95% confidence interval (CI): 0.278-0.954; P=0.03], and the T-wave top amplitude in the aVR leads (OR: 0.998; 95% CI: 0.996-0.999; P<0.001) and the HRV_SDNN (OR: 0.988; 95% CI: 0.976-1.000; P=0.045) had independent causal effects on the risk of bradycardia.

Conclusions: The HRV_SDNN had an independent causal effect on AF, while the HRV_SDNN and T-wave top amplitude in the aVR leads had independent causal effects on bradycardia, which suggests that some of the electrocardiographic parameters have preventive effects on the incidence of AF and bradycardia.

背景:观察性研究表明,心率(HR)、心率变异性(HRV)、P 波末端力、P 波持续时间、T 波振幅和 PR 间期与心房颤动(AF)或心动过缓的风险因素有关。心律失常与许多住院原因有关。然而,观察性研究容易受到尚未确定的混杂因素的影响。本研究的目的是通过孟德尔随机分析来明确因果关系:我们利用欧洲人群的全基因组关联研究(GWAS)数据进行了双样本和多变量孟德尔随机化(MVMR)分析,以评估心率的总体和直接因果效应、三种心率变异特征、P 波末端力、P 波持续时间、五导联模式下的 T 波顶部振幅和 PR 间期对房颤(191 205 人)、心动过缓(463 010 人)和室上性心动过速(SVT)(463 010 人)风险的总体和直接因果效应。结果单变量磁共振分析结果显示了以下显著因果效应:基因预测的 PR 间期越高,房颤风险越低;心率和 T 波顶部振幅(aVR 导联和 V3 + V4 + aVL 导联)越高,心动过缓风险越低;心率越高和 PR 间期越低,室上性心动过速风险越高。多变量磁共振结果表明,HRV_正常与正常间期的标准偏差(SDNN)对房颤风险有独立的因果效应[比值比(OR):0.515;95% 置信区间(CI):0.278-0.954;P=0.03],aVR 导联的 T 波顶部振幅(OR:0.998;95% CI:0.996-0.999;PC 结论:HRV_正常与正常间期的标准偏差(SDNN)对房颤风险有独立的因果效应[比值比(OR):0.515;95% 置信区间(CI):0.278-0.954;P=0.03]:HRV_SDNN对房颤有独立的因果效应,而HRV_SDNN和aVR导联的T波顶部振幅对心动过缓有独立的因果效应,这表明某些心电图参数对房颤和心动过缓的发生率有预防作用。
{"title":"Exploring the impact of electrocardiographic parameters on the risk of common arrhythmias: a two-sample Mendelian randomization study.","authors":"Guangheng Wu, Qiaoyun Zhang, Jie Zhang, Jinqi Zhu, Deqiang Zheng, Youxin Wang, Lijuan Wu","doi":"10.21037/jtd-24-814","DOIUrl":"10.21037/jtd-24-814","url":null,"abstract":"<p><strong>Background: </strong>Observational studies have shown that heart rate (HR), heart rate variability (HRV), P-wave terminal force, P-wave duration, T-wave amplitude and PR interval are associated with risk factors for atrial fibrillation (AF) or bradycardia. Arrhythmias are associated with many causes of hospitalization. However, observational studies are susceptible to confounding factors that have not yet been identified. The objective of this study was to clarify the causal relationships by Mendelian randomization analysis.</p><p><strong>Methods: </strong>We conducted a two-sample and multivariate Mendelian randomization (MVMR) analysis using genome-wide association study (GWAS) data from a European population to assess the total and direct causal effects of HR, three HRV traits, P-wave terminal force, P-wave duration, T-wave top amplitude in five-lead modes, and the PR interval on the risk of AF (N=191,205), bradycardia (N=463,010), and supraventricular tachycardia (SVT) (N=463,010).</p><p><strong>Results: </strong>The results of the univariate MR analysis revealed the following significant causal effects: the higher the genetically predicted PR interval, the lower the risk of AF; the higher the HR and T-wave top amplitude (aVR leads and V3 + V4 + aVL leads), the lower the risk of bradycardia; and the higher HR and the lower PR interval, the higher the risk of SVT. The multivariate MR results indicated that the HRV_standard deviation of the normal-to-normal (SDNN) interval had an independent causal effect on the risk of AF [odds ratio (OR): 0.515; 95% confidence interval (CI): 0.278-0.954; P=0.03], and the T-wave top amplitude in the aVR leads (OR: 0.998; 95% CI: 0.996-0.999; P<0.001) and the HRV_SDNN (OR: 0.988; 95% CI: 0.976-1.000; P=0.045) had independent causal effects on the risk of bradycardia.</p><p><strong>Conclusions: </strong>The HRV_SDNN had an independent causal effect on AF, while the HRV_SDNN and T-wave top amplitude in the aVR leads had independent causal effects on bradycardia, which suggests that some of the electrocardiographic parameters have preventive effects on the incidence of AF and bradycardia.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320266/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of group II pulmonary hypertension on congestive heart failure patients admitted with ST elevation myocardial infarction, a nationwide study. 一项全国性研究:II组肺动脉高压对因ST段抬高心肌梗死入院的充血性心力衰竭患者的影响。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-05 DOI: 10.21037/jtd-24-221
Mohamad El Labban, Mikael R Mir, Alexandra Abruzzo, Sydney Boike, Fayreal A Niaz, Natasha T Vo, Ibtisam Rauf, Syed A Khan

Background: Pulmonary hypertension (PH) is a condition where the blood pressure increases in the pulmonary arteries, leading to reduced oxygen delivery to the body's tissues due to increased blood flow resistance. This condition can result in right ventricular hypertrophy, low cardiac output, and ischemia. In this study, the authors aim to investigate the impact of group II PH (GIIPH) on patients with congestive heart failure who were admitted with ST elevation myocardial infarction (STEMI) through a retrospective cohort study.

Methods: Using the National Inpatient Sample (NIS) database from 2017 to 2020, a retrospective cross-sectional study of adult patients with a principal diagnosis of STEMI with a secondary diagnosis with or without GIIPH according to ICD-10 (International Classification of Disease, 10th edition) codes. Several demographics, including age, race, and gender, were analyzed. The primary endpoint was mortality, while the secondary endpoints included cardiogenic shock, mechanical intubation, length of stay in days, and patient charge in dollars. Multivariate logistic regression model analysis was used to adjust for confounders, with a P value less than 0.05 considered statistically significant.

Results: The study included 26,925 patients admitted with a STEMI, 95 of whom had GIIPH. The mean age for patients with and without PH was 66.6 and 67.5 years, respectively. In the PH group, 37% were females compared to 34% in the non-PH group. The in-hospital mortality rate was higher in the PH group (31.6% vs. 9.6%, P<0.001, adjusted odds ratio (aOR) =3.33, P=0.02). The rates and adjusted odds of cardiogenic shock and mechanical ventilation were higher in the PH groups (aOR =1.15 and 2.14, respectively) but not statistically significant. Patients with PH had a longer length of stay and a higher total charge.

Conclusions: GIIPH was associated with worse clinical and economic outcomes in heart failure patients admitted with STEMI.

背景:肺动脉高压(PH)是指肺动脉内的血压升高,由于血流阻力增加,导致向身体组织输送的氧气减少。这种情况会导致右心室肥大、心输出量低和缺血。在本研究中,作者旨在通过一项回顾性队列研究,探讨 II 组 PH(GIIPH)对因 ST 段抬高型心肌梗死(STEMI)入院的充血性心力衰竭患者的影响:利用2017年至2020年全国住院患者抽样(NIS)数据库,根据ICD-10(国际疾病分类,第10版)编码,对主要诊断为STEMI、次要诊断为GIIPH或不伴有GIIPH的成年患者进行回顾性横断面研究。对包括年龄、种族和性别在内的多项人口统计学数据进行了分析。主要终点是死亡率,次要终点包括心源性休克、机械插管、住院天数和患者费用(美元)。采用多变量逻辑回归模型分析来调整混杂因素,P 值小于 0.05 视为具有统计学意义:研究纳入了 26925 名 STEMI 患者,其中 95 人患有 GIIPH。PH 组和非 PH 组患者的平均年龄分别为 66.6 岁和 67.5 岁。在PH组中,女性占37%,而非PH组中女性占34%。PH组的院内死亡率更高(31.6%对9.6%,PC结论:GIIPH与STEMI心衰患者较差的临床和经济预后有关。
{"title":"The impact of group II pulmonary hypertension on congestive heart failure patients admitted with ST elevation myocardial infarction, a nationwide study.","authors":"Mohamad El Labban, Mikael R Mir, Alexandra Abruzzo, Sydney Boike, Fayreal A Niaz, Natasha T Vo, Ibtisam Rauf, Syed A Khan","doi":"10.21037/jtd-24-221","DOIUrl":"10.21037/jtd-24-221","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary hypertension (PH) is a condition where the blood pressure increases in the pulmonary arteries, leading to reduced oxygen delivery to the body's tissues due to increased blood flow resistance. This condition can result in right ventricular hypertrophy, low cardiac output, and ischemia. In this study, the authors aim to investigate the impact of group II PH (GIIPH) on patients with congestive heart failure who were admitted with ST elevation myocardial infarction (STEMI) through a retrospective cohort study.</p><p><strong>Methods: </strong>Using the National Inpatient Sample (NIS) database from 2017 to 2020, a retrospective cross-sectional study of adult patients with a principal diagnosis of STEMI with a secondary diagnosis with or without GIIPH according to ICD-10 (International Classification of Disease, 10th edition) codes. Several demographics, including age, race, and gender, were analyzed. The primary endpoint was mortality, while the secondary endpoints included cardiogenic shock, mechanical intubation, length of stay in days, and patient charge in dollars. Multivariate logistic regression model analysis was used to adjust for confounders, with a P value less than 0.05 considered statistically significant.</p><p><strong>Results: </strong>The study included 26,925 patients admitted with a STEMI, 95 of whom had GIIPH. The mean age for patients with and without PH was 66.6 and 67.5 years, respectively. In the PH group, 37% were females compared to 34% in the non-PH group. The in-hospital mortality rate was higher in the PH group (31.6% <i>vs.</i> 9.6%, P<0.001, adjusted odds ratio (aOR) =3.33, P=0.02). The rates and adjusted odds of cardiogenic shock and mechanical ventilation were higher in the PH groups (aOR =1.15 and 2.14, respectively) but not statistically significant. Patients with PH had a longer length of stay and a higher total charge.</p><p><strong>Conclusions: </strong>GIIPH was associated with worse clinical and economic outcomes in heart failure patients admitted with STEMI.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of bridging veno-venous extracorporeal membrane oxygenation to COVID-19 lung transplantation. 桥接静脉体外膜氧合对 COVID-19 肺移植的影响。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-26 DOI: 10.21037/jtd-24-132
Takahide Toyoda, Benjamin Louis Thomae, Taisuke Kaiho, Emily Jeong Cerier, Rade Tomic, G R Scott Budinger, Ankit Bharat, Chitaru Kurihara

Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) therapy is being increasingly used as respiratory support for patients with severe coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS). However, the long-term outcome of VV-ECMO as a bridge to lung transplantation in COVID-19-associated ARDS remains unclear, hence the purpose of this study aimed to evaluate its long-term outcome, safety, and feasibility.

Methods: This was a retrospective cohort study from an institutional lung transplantation database between June 2020 and June 2022. Data on demographics, pre-transplantation laboratory values, postoperative outcomes, preoperative and postoperative transthoracic echocardiography findings, and survival rates were collected. Chi-square, Mann-Whitney U, Student's t, Kaplan-Meier, and Wilcoxon signed-rank tests were used for analysis.

Results: Twenty-five patients with COVID-19-associated ARDS underwent lung transplant surgery with VV-ECMO bridge. Unfortunately, six patients with COVID-19-associated ARDS using VV-ECMO died while waiting for transplantation during the same study period. Patients with VV-ECMO bridge were a more severe cohort than 16 patients without VV-ECMO bridge (lung allocation score: 88.1 vs. 74.9, P<0.001). These patients had longer intensive care unit and hospital stays (P=0.03 and P=0.02, respectively) and a higher incidence of complications after lung transplantation. The one-year survival rate of patients with VV-ECMO bridge was lower than that of patients without (78.3% vs. 100.0%, P=0.06), but comparable to that of patients with other lung transplant indications (84.2%, P=0.95). Echocardiography showed a decrease in the right ventricular systolic pressure (P=0.01), confirming that lung transplantation improved right heart function.

Conclusions: Our findings suggest that VV-ECMO can be used to safely bridge patients with COVID-19 associated ARDS with right heart failure.

背景:静脉-静脉体外膜氧合(VV-ECMO)疗法正越来越多地被用作2019年严重冠状病毒病(COVID-19)相关急性呼吸窘迫综合征(ARDS)患者的呼吸支持。然而,VV-ECMO作为COVID-19相关ARDS肺移植的桥梁,其长期疗效仍不明确,因此本研究旨在评估其长期疗效、安全性和可行性:本研究是一项回顾性队列研究,研究对象为 2020 年 6 月至 2022 年 6 月期间的肺移植机构数据库。收集了有关人口统计学、移植前实验室值、术后结果、术前和术后经胸超声心动图检查结果以及存活率的数据。分析方法包括Chi-square、Mann-Whitney U、Student's t、Kaplan-Meier和Wilcoxon符号秩检验:结果:25 名 COVID-19 相关 ARDS 患者在 VV-ECMO 桥接下接受了肺移植手术。遗憾的是,在同一研究期间,6 名使用 VV-ECMO 的 COVID-19 相关 ARDS 患者在等待移植期间死亡。与16例未使用VV-ECMO桥接的患者相比,使用VV-ECMO桥接的患者病情更为严重(肺分配评分:88.1 vs. 74.9,Pvs. 100.0%,P=0.06),但与其他肺移植适应症患者的病情相当(84.2%,P=0.95)。超声心动图显示右心室收缩压下降(P=0.01),证实肺移植改善了右心功能:我们的研究结果表明,VV-ECMO 可用于安全地为 COVID-19 相关 ARDS 右心衰竭患者搭桥。
{"title":"Impact of bridging veno-venous extracorporeal membrane oxygenation to COVID-19 lung transplantation.","authors":"Takahide Toyoda, Benjamin Louis Thomae, Taisuke Kaiho, Emily Jeong Cerier, Rade Tomic, G R Scott Budinger, Ankit Bharat, Chitaru Kurihara","doi":"10.21037/jtd-24-132","DOIUrl":"10.21037/jtd-24-132","url":null,"abstract":"<p><strong>Background: </strong>Veno-venous extracorporeal membrane oxygenation (VV-ECMO) therapy is being increasingly used as respiratory support for patients with severe coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS). However, the long-term outcome of VV-ECMO as a bridge to lung transplantation in COVID-19-associated ARDS remains unclear, hence the purpose of this study aimed to evaluate its long-term outcome, safety, and feasibility.</p><p><strong>Methods: </strong>This was a retrospective cohort study from an institutional lung transplantation database between June 2020 and June 2022. Data on demographics, pre-transplantation laboratory values, postoperative outcomes, preoperative and postoperative transthoracic echocardiography findings, and survival rates were collected. Chi-square, Mann-Whitney U, Student's t, Kaplan-Meier, and Wilcoxon signed-rank tests were used for analysis.</p><p><strong>Results: </strong>Twenty-five patients with COVID-19-associated ARDS underwent lung transplant surgery with VV-ECMO bridge. Unfortunately, six patients with COVID-19-associated ARDS using VV-ECMO died while waiting for transplantation during the same study period. Patients with VV-ECMO bridge were a more severe cohort than 16 patients without VV-ECMO bridge (lung allocation score: 88.1 <i>vs.</i> 74.9, P<0.001). These patients had longer intensive care unit and hospital stays (P=0.03 and P=0.02, respectively) and a higher incidence of complications after lung transplantation. The one-year survival rate of patients with VV-ECMO bridge was lower than that of patients without (78.3% <i>vs.</i> 100.0%, P=0.06), but comparable to that of patients with other lung transplant indications (84.2%, P=0.95). Echocardiography showed a decrease in the right ventricular systolic pressure (P=0.01), confirming that lung transplantation improved right heart function.</p><p><strong>Conclusions: </strong>Our findings suggest that VV-ECMO can be used to safely bridge patients with COVID-19 associated ARDS with right heart failure.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jejunostomy feeding plus oral feeding versus intravenous nutrition plus oral feeding after esophageal cancer resection: a comparative retrospective cohort study. 食管癌切除术后空肠造口术加口服喂养与静脉营养加口服喂养的比较:一项回顾性队列研究。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-06-21 DOI: 10.21037/jtd-24-657
Maoxiu Yuan, Hai Zhang, Mingchao Wei, Caiyun Lan, Zhenyang Zhang, Ling Huang, Jianzhong Zhou, Haiquan He, Kazuo Koyanagi, Qingyi Feng, Jiangbo Lin

Background: There are multiple choices for the nutritional management mode after esophageal cancer surgery. Currently, there is still controversy regarding which nutritional management mode has an impact on the postoperative recovery and overall survival (OS) of patients. This study aims to compare the differences between two commonly used clinical nutritional management modes: jejunostomy feeding plus oral intake (JF plus OI) and intravenous nutrition plus oral intake (IN plus OI), in terms of short-term efficacy and 3-year OS, in order to further explore the optimal mode of enteral nutrition management after esophageal cancer surgery.

Methods: We evaluated esophageal cancer patients who underwent radical surgery at Union Hospital of Fujian Medical University between January 1, 2010 and January 1, 2020. The purpose of this analysis was to compare the perioperative complications, Nutritional Risk Screening 2002 (NRS2002) nutritional scores at 1 week, 2 weeks, 1 month, and 3 months after surgery, as well as the 3-year OS rates, between two different nutritional management approaches: JF plus OI and IN plus OI following esophageal cancer surgery.

Results: Among the 822 patients included, 668 and 154 patients belonged to JF plus OI and IN plus OI groups, respectively. After propensity score matching, 149 patients per group were evaluated. The amount of gastric drainage fluid was higher in the IN plus OI group (P<0.05), and the incidence of postoperative gastrointestinal emptying disorder and intestinal obstruction was significantly higher in the JF plus OI group (P<0.05). The IN plus OI group had a higher incidence of perioperative hypoproteinemia (P<0.05), and a higher risk of malnutrition in 2 weeks after surgery (P<0.05). The 3-year OS was not significantly different (P>0.05).

Conclusions: JF plus OI may be the preferable nutritional management approach after esophageal cancer resection as it can potentially reduce perioperative nutritional deficiency. However, attention should be paid to the risk of gastrointestinal emptying and intestinal obstruction associated with JF.

背景:食管癌术后的营养管理模式有多种选择。目前,关于哪种营养管理模式会影响患者的术后恢复和总生存率(OS)仍存在争议。本研究旨在比较空肠造口喂养加口服(JF 加 OI)和静脉营养加口服(IN 加 OI)两种临床常用营养管理模式在短期疗效和 3 年 OS 方面的差异,以进一步探讨食管癌术后肠内营养管理的最佳模式:我们对 2010 年 1 月 1 日至 2020 年 1 月 1 日期间在福建医科大学附属协和医院接受根治术的食管癌患者进行了评估。分析的目的是比较两种不同营养管理方法的围手术期并发症、术后 1 周、2 周、1 个月和 3 个月的营养风险筛查 2002(NRS2002)营养评分以及 3 年 OS 率:结果:在纳入的 822 例患者中,分别有 668 例和 154 例患者属于 JF 加 OI 组和 IN 加 OI 组。经过倾向评分匹配后,每组有 149 名患者接受了评估。IN加OI组的胃引流液量更高(P0.05):结论:JF 加 OI 可能是食管癌切除术后较好的营养管理方法,因为它有可能减少围手术期的营养缺乏。然而,应注意与 JF 相关的胃肠道排空和肠梗阻风险。
{"title":"Jejunostomy feeding plus oral feeding versus intravenous nutrition plus oral feeding after esophageal cancer resection: a comparative retrospective cohort study.","authors":"Maoxiu Yuan, Hai Zhang, Mingchao Wei, Caiyun Lan, Zhenyang Zhang, Ling Huang, Jianzhong Zhou, Haiquan He, Kazuo Koyanagi, Qingyi Feng, Jiangbo Lin","doi":"10.21037/jtd-24-657","DOIUrl":"10.21037/jtd-24-657","url":null,"abstract":"<p><strong>Background: </strong>There are multiple choices for the nutritional management mode after esophageal cancer surgery. Currently, there is still controversy regarding which nutritional management mode has an impact on the postoperative recovery and overall survival (OS) of patients. This study aims to compare the differences between two commonly used clinical nutritional management modes: jejunostomy feeding plus oral intake (JF plus OI) and intravenous nutrition plus oral intake (IN plus OI), in terms of short-term efficacy and 3-year OS, in order to further explore the optimal mode of enteral nutrition management after esophageal cancer surgery.</p><p><strong>Methods: </strong>We evaluated esophageal cancer patients who underwent radical surgery at Union Hospital of Fujian Medical University between January 1, 2010 and January 1, 2020. The purpose of this analysis was to compare the perioperative complications, Nutritional Risk Screening 2002 (NRS2002) nutritional scores at 1 week, 2 weeks, 1 month, and 3 months after surgery, as well as the 3-year OS rates, between two different nutritional management approaches: JF plus OI and IN plus OI following esophageal cancer surgery.</p><p><strong>Results: </strong>Among the 822 patients included, 668 and 154 patients belonged to JF plus OI and IN plus OI groups, respectively. After propensity score matching, 149 patients per group were evaluated. The amount of gastric drainage fluid was higher in the IN plus OI group (P<0.05), and the incidence of postoperative gastrointestinal emptying disorder and intestinal obstruction was significantly higher in the JF plus OI group (P<0.05). The IN plus OI group had a higher incidence of perioperative hypoproteinemia (P<0.05), and a higher risk of malnutrition in 2 weeks after surgery (P<0.05). The 3-year OS was not significantly different (P>0.05).</p><p><strong>Conclusions: </strong>JF plus OI may be the preferable nutritional management approach after esophageal cancer resection as it can potentially reduce perioperative nutritional deficiency. However, attention should be paid to the risk of gastrointestinal emptying and intestinal obstruction associated with JF.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol for a single-arm, multicenter, prospective, confirmatory phase III trial of wedge resection for invasive ground glass opacity-featured lung cancer with a size ≤2 cm and a consolidation tumor ratio between 0.25 and 0.5 (ECTOP-1020 study). 单臂、多中心、前瞻性、确证性 III 期试验:楔形切除术治疗浸润性玻璃样不透明肺癌,肿瘤大小≤2 厘米,合并肿瘤比率介于 0.25 和 0.5 之间(ECTOP-1020 研究)。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-09 DOI: 10.21037/jtd-24-440
Tong Li, Fangqiu Fu, Yang Zhang, Haiquan Chen

Background: Segmentectomy is the current standard treatment for ground glass opacity (GGO)-featured lung cancer patients with a tumor size ≤2 cm and a consolidation tumor ratio (CTR) between 0.25 and 0.5. However, compared with wedge resection, segmentectomy destroys the patient's hilar structure and consumes more lung parenchyma. A recent study demonstrated that wedge resection could yield comparable results for this group of patients.

Methods: This study aimed to confirm the noninferiority of wedge resection over standard surgery in invasive GGO-featured lung cancer patients with a size ≤2 cm and a CTR between 0.25 and 0.5, as measured by 5-year overall survival (OS). The primary endpoint is 5-year OS. The secondary endpoints are 5-year recurrence-free survival (RFS), the R0 resection rate, pulmonary function, recurrence and metastasis sites, and adverse events after surgery. During the trial period, 286 patients are enrolled from six Chinese institutions.

Discussion: The primary results of this study will be actively disseminated through manuscript publications and conference presentations. This prospective study will evaluate the surgical efficacy and safety of wedge resection for small (tumor size ≤2 cm with a CTR between 0.25 and 0.5) invasive GGO-featured lung cancer and will support the standardization of this surgical strategy.

Trial registration: This trial has been registered on ClinicalTrial.gov (No. NCT06102161).

背景:对于肿瘤大小≤2 厘米、合并肿瘤比(CTR)在 0.25 至 0.5 之间的玻璃样不透明(GGO)特征肺癌患者,分段切除术是目前的标准治疗方法。然而,与楔形切除术相比,分段切除术会破坏患者的肺门结构,消耗更多的肺实质。最近的一项研究表明,楔形切除术可为这类患者带来相当的效果:本研究旨在证实,对于大小≤2 厘米、CTR 在 0.25 和 0.5 之间的侵袭性 GGO 特征肺癌患者,以 5 年总生存期(OS)来衡量,楔形切除术的效果优于标准手术。主要终点是5年OS。次要终点是5年无复发生存率(RFS)、R0切除率、肺功能、复发和转移部位以及术后不良反应。在试验期间,来自中国六家医疗机构的 286 名患者参与了试验:本研究的主要结果将通过手稿发表和会议发言积极传播。这项前瞻性研究将评估楔形切除术治疗小面积(肿瘤大小≤2厘米,CTR介于0.25和0.5之间)浸润性GGO特征肺癌的手术疗效和安全性,并支持该手术策略的标准化:该试验已在ClinicalTrial.gov网站注册(编号:NCT06102161)。
{"title":"Protocol for a single-arm, multicenter, prospective, confirmatory phase III trial of wedge resection for invasive ground glass opacity-featured lung cancer with a size ≤2 cm and a consolidation tumor ratio between 0.25 and 0.5 (ECTOP-1020 study).","authors":"Tong Li, Fangqiu Fu, Yang Zhang, Haiquan Chen","doi":"10.21037/jtd-24-440","DOIUrl":"10.21037/jtd-24-440","url":null,"abstract":"<p><strong>Background: </strong>Segmentectomy is the current standard treatment for ground glass opacity (GGO)-featured lung cancer patients with a tumor size ≤2 cm and a consolidation tumor ratio (CTR) between 0.25 and 0.5. However, compared with wedge resection, segmentectomy destroys the patient's hilar structure and consumes more lung parenchyma. A recent study demonstrated that wedge resection could yield comparable results for this group of patients.</p><p><strong>Methods: </strong>This study aimed to confirm the noninferiority of wedge resection over standard surgery in invasive GGO-featured lung cancer patients with a size ≤2 cm and a CTR between 0.25 and 0.5, as measured by 5-year overall survival (OS). The primary endpoint is 5-year OS. The secondary endpoints are 5-year recurrence-free survival (RFS), the R0 resection rate, pulmonary function, recurrence and metastasis sites, and adverse events after surgery. During the trial period, 286 patients are enrolled from six Chinese institutions.</p><p><strong>Discussion: </strong>The primary results of this study will be actively disseminated through manuscript publications and conference presentations. This prospective study will evaluate the surgical efficacy and safety of wedge resection for small (tumor size ≤2 cm with a CTR between 0.25 and 0.5) invasive GGO-featured lung cancer and will support the standardization of this surgical strategy.</p><p><strong>Trial registration: </strong>This trial has been registered on ClinicalTrial.gov (No. NCT06102161).</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchoscopic holmium laser ablation continuous cryoablation for the treatment of airway stenosis caused by tissue hyperplasia after tracheal intubation: clinical case observation. 支气管镜下钬激光消融连续低温消融术治疗气管插管后组织增生引起的气道狭窄:临床病例观察。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-23 DOI: 10.21037/jtd-24-67
Qingjie Yang, Shenghua Lv, Qingtian Li, Linhui Lan, Xiaoyan Sun, Xinhai Feng, Kaibao Han

This study aimed to design a standardised bronchoscopic holmium laser ablation continuous cryoablation for the treatment of airway stenosis caused by tissue hyperplasia after tracheal intubation and to retrospectively analyse its safety and feasibility. We collected the data of patients who had undergone bronchoscopic holmium laser ablation continuous cryoablation due to airway stenosis caused by tracheal mucosal tissue hyperplasia after tracheal intubation. The patients' baseline characteristics, ablation effects, surgical complications and other data were analysed. In total, 16 patients were enrolled in this study. On average, airway stenosis occurred 96.00 (interquartile range, 69.75-152.50) days after tracheal intubation and bronchoscopic holmium laser ablation continuous cryoablation took an average of 90.38 minutes (standard deviation: 16.78). After the first continuous cryoablation, 75.0% (12/16) of the patients had complete ablation of hyperplastic tissue, and 25.0% (4/16) had most of the hyperplastic tissue (>50%) removed. Altogether, 18.75% (3/16) and 6.25% (1/16) of the patients had complete ablation of hyperplastic tissue after the second and third cryoablation, respectively. Moreover, one patient (6.25%) had minimal wound bleeding postoperatively, and no other surgical complications occurred. No airway stenosis was found in all enrolled patients during follow-up 1 and 6 months after the last cryoablation. According to the above results of our small sample study indicated that bronchoscopic holmium laser ablation continuous cryoablation seems safe and effective for treating airway stenosis caused by tissue hyperplasia after tracheal intubation.

本研究旨在设计一种标准化的支气管镜钬激光消融连续低温消融术,用于治疗气管插管后组织增生引起的气道狭窄,并对其安全性和可行性进行回顾性分析。我们收集了因气管插管后气管粘膜组织增生导致气道狭窄而接受支气管镜下钬激光消融连续低温消融术的患者数据。对患者的基线特征、消融效果、手术并发症和其他数据进行了分析。共有 16 名患者参与了这项研究。气道狭窄平均发生在气管插管后 96.00 天(四分位距为 69.75-152.50 天),支气管镜钬激光消融连续低温消融平均耗时 90.38 分钟(标准差:16.78)。第一次连续低温消融术后,75.0%(12/16)的患者完全消融了增生组织,25.0%(4/16)的患者切除了大部分增生组织(>50%)。在第二次和第三次冷冻消融术后,分别有 18.75% (3/16)和 6.25% (1/16)的患者完全消融了增生组织。此外,一名患者(6.25%)术后伤口出血量极少,未出现其他手术并发症。在最后一次冷冻消融术后 1 个月和 6 个月的随访中,所有入选患者均未发现气道狭窄。上述小样本研究结果表明,支气管镜下钬激光消融连续冷冻消融术治疗气管插管后组织增生引起的气道狭窄是安全有效的。
{"title":"Bronchoscopic holmium laser ablation continuous cryoablation for the treatment of airway stenosis caused by tissue hyperplasia after tracheal intubation: clinical case observation.","authors":"Qingjie Yang, Shenghua Lv, Qingtian Li, Linhui Lan, Xiaoyan Sun, Xinhai Feng, Kaibao Han","doi":"10.21037/jtd-24-67","DOIUrl":"10.21037/jtd-24-67","url":null,"abstract":"<p><p>This study aimed to design a standardised bronchoscopic holmium laser ablation continuous cryoablation for the treatment of airway stenosis caused by tissue hyperplasia after tracheal intubation and to retrospectively analyse its safety and feasibility. We collected the data of patients who had undergone bronchoscopic holmium laser ablation continuous cryoablation due to airway stenosis caused by tracheal mucosal tissue hyperplasia after tracheal intubation. The patients' baseline characteristics, ablation effects, surgical complications and other data were analysed. In total, 16 patients were enrolled in this study. On average, airway stenosis occurred 96.00 (interquartile range, 69.75-152.50) days after tracheal intubation and bronchoscopic holmium laser ablation continuous cryoablation took an average of 90.38 minutes (standard deviation: 16.78). After the first continuous cryoablation, 75.0% (12/16) of the patients had complete ablation of hyperplastic tissue, and 25.0% (4/16) had most of the hyperplastic tissue (>50%) removed. Altogether, 18.75% (3/16) and 6.25% (1/16) of the patients had complete ablation of hyperplastic tissue after the second and third cryoablation, respectively. Moreover, one patient (6.25%) had minimal wound bleeding postoperatively, and no other surgical complications occurred. No airway stenosis was found in all enrolled patients during follow-up 1 and 6 months after the last cryoablation. According to the above results of our small sample study indicated that bronchoscopic holmium laser ablation continuous cryoablation seems safe and effective for treating airway stenosis caused by tissue hyperplasia after tracheal intubation.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double-bar technique for the correction of asymmetric pectus excavatum. 矫正不对称胸肌的双杠技术。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-09 DOI: 10.21037/jtd-23-1650
Wongi Woo, Duk Hwan Moon, Jimin Lee, Bong Jun Kim, Sungsoo Lee

Background: Minimally invasive repair of pectus excavatum (MIRPE) improves clinical outcomes and chest wall morphology. However, asymmetry in patients with pectus excavatum (PE) remains as an important issue, even after surgery. Here, we evaluated the benefit of double-bar technique in achieving a symmetric chest wall.

Methods: This retrospective study included 79 patients with PE who underwent MIRPE between 2017 and 2021. The patients were divided into the double- or non-double-bar groups. Asymmetric degree (AD) and sternal rotation angle (SRA) were used to assess the severity of asymmetry based on computed tomography (CT) images. The primary outcome was the change in radiologic parameters. Secondary outcomes were clinical results, including hospital stay, pain scores, and complication rates. Subgroup analysis of patients with preoperative asymmetric PE was performed.

Results: Patients in the double-bar group (n=23) were younger than those in the non-double-bar group (n=56). Additionally, the double-bar group exhibited lower pain scores and shorter hospital stay. Based on radiological assessments, the double-bar group demonstrated a greater decrease in AD without compromising improvement in the Haller index (HI). The benefit of the double-bar technique was more obvious among patients with asymmetry with a preoperative AD >5%, resulting in a significant reduction in AD. In this subgroup, a better correction of sternal rotation was observed.

Conclusions: The double-bar technique may be a promising option for correcting asymmetry in patients with PE. Simplified AD and SRA radiologic assessments can be used to evaluate improvements in chest wall configuration.

背景:乳房下垂微创修复术(MIRPE)可改善临床疗效和胸壁形态。然而,即使在手术后,胸肌下垂(PE)患者的不对称仍是一个重要问题。在此,我们评估了双杠技术在实现胸壁对称方面的益处:这项回顾性研究纳入了 2017 年至 2021 年间接受 MIRPE 的 79 例 PE 患者。患者被分为双杠组和非双杠组。不对称程度(AD)和胸骨旋转角度(SRA)用于根据计算机断层扫描(CT)图像评估不对称的严重程度。主要结果是放射学参数的变化。次要结果是临床结果,包括住院时间、疼痛评分和并发症发生率。对术前有不对称PE的患者进行了分组分析:结果:双杠组患者(23 人)比非双杠组患者(56 人)年轻。此外,双杠组患者的疼痛评分较低,住院时间较短。根据放射学评估,双杠组的 AD 下降幅度更大,但不影响哈勒指数(HI)的改善。在术前AD>5%的不对称患者中,双杠技术的优势更为明显,从而显著降低了AD。在这一亚组中,胸骨旋转的矫正效果更好:结论:双杠技术可能是矫正 PE 患者不对称的一个很有前途的选择。简化的 AD 和 SRA 放射学评估可用于评估胸壁构型的改善情况。
{"title":"Double-bar technique for the correction of asymmetric pectus excavatum.","authors":"Wongi Woo, Duk Hwan Moon, Jimin Lee, Bong Jun Kim, Sungsoo Lee","doi":"10.21037/jtd-23-1650","DOIUrl":"10.21037/jtd-23-1650","url":null,"abstract":"<p><strong>Background: </strong>Minimally invasive repair of pectus excavatum (MIRPE) improves clinical outcomes and chest wall morphology. However, asymmetry in patients with pectus excavatum (PE) remains as an important issue, even after surgery. Here, we evaluated the benefit of double-bar technique in achieving a symmetric chest wall.</p><p><strong>Methods: </strong>This retrospective study included 79 patients with PE who underwent MIRPE between 2017 and 2021. The patients were divided into the double- or non-double-bar groups. Asymmetric degree (AD) and sternal rotation angle (SRA) were used to assess the severity of asymmetry based on computed tomography (CT) images. The primary outcome was the change in radiologic parameters. Secondary outcomes were clinical results, including hospital stay, pain scores, and complication rates. Subgroup analysis of patients with preoperative asymmetric PE was performed.</p><p><strong>Results: </strong>Patients in the double-bar group (n=23) were younger than those in the non-double-bar group (n=56). Additionally, the double-bar group exhibited lower pain scores and shorter hospital stay. Based on radiological assessments, the double-bar group demonstrated a greater decrease in AD without compromising improvement in the Haller index (HI). The benefit of the double-bar technique was more obvious among patients with asymmetry with a preoperative AD >5%, resulting in a significant reduction in AD. In this subgroup, a better correction of sternal rotation was observed.</p><p><strong>Conclusions: </strong>The double-bar technique may be a promising option for correcting asymmetry in patients with PE. Simplified AD and SRA radiologic assessments can be used to evaluate improvements in chest wall configuration.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning-based prediction of off-pump coronary artery bypass grafting-associated acute kidney injury. 基于机器学习的冠状动脉旁路移植术后急性肾损伤预测。
IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM Pub Date : 2024-07-30 Epub Date: 2024-07-22 DOI: 10.21037/jtd-24-711
Yuezi Song, Wenqian Zhai, Songnan Ma, Yubo Wu, Min Ren, Jef Van den Eynde, Paolo Nardi, Philip Y K Pang, Jason M Ali, Jiange Han, Zhigang Guo

Background: The cardiac surgery-associated acute kidney injury (CSA-AKI) occurs in up to 1 out of 3 patients. Off-pump coronary artery bypass grafting (OPCABG) is one of the major cardiac surgeries leading to CSA-AKI. Early identification and timely intervention are of clinical significance for CSA-AKI. In this study, we aimed to establish a prediction model of off-pump coronary artery bypass grafting-associated acute kidney injury (OPCABG-AKI) after surgery based on machine learning methods.

Methods: The preoperative and intraoperative data of 1,041 patients who underwent OPCABG in Chest Hospital, Tianjin University from June 1, 2021 to April 30, 2023 were retrospectively collected. The definition of OPCABG-AKI was based on the 2012 Kidney Disease Improving Global Outcomes (KDIGO) criteria. The baseline data and intraoperative time series data were included in the dataset, which were preprocessed separately. A total of eight machine learning models were constructed based on the baseline data: logistic regression (LR), gradient-boosting decision tree (GBDT), eXtreme gradient boosting (XGBoost), adaptive boosting (AdaBoost), random forest (RF), support vector machine (SVM), k-nearest neighbor (KNN), and decision tree (DT). The intraoperative time series data were extracted using a long short-term memory (LSTM) deep learning model. The baseline data and intraoperative features were then integrated through transfer learning and fused into each of the eight machine learning models for training. Based on the calculation of accuracy and area under the curve (AUC) of the prediction model, the best model was selected to establish the final OPCABG-AKI risk prediction model. The importance of features was calculated and ranked by DT model, to identify the main risk factors.

Results: Among 701 patients included in the study, 73 patients (10.4%) developed OPCABG-AKI. The GBDT model was shown to have the best predictions, both based on baseline data only (AUC =0.739, accuracy: 0.943) as well as based on baseline and intraoperative datasets (AUC =0.861, accuracy: 0.936). The ranking of importance of features of the GBDT model showed that use of insulin aspart was the most important predictor of OPCABG-AKI, followed by use of acarbose, spironolactone, alfentanil, dezocine, levosimendan, clindamycin, history of myocardial infarction, and gender.

Conclusions: A GBDT-based model showed excellent performance for the prediction of OPCABG-AKI. The fusion of preoperative and intraoperative data can improve the accuracy of predicting OPCABG-AKI.

背景:每 3 名患者中就有 1 名会发生心脏手术相关急性肾损伤(CSA-AKI)。体外循环冠状动脉旁路移植术(OPCABG)是导致 CSA-AKI 的主要心脏手术之一。早期识别和及时干预对 CSA-AKI 具有重要的临床意义。在这项研究中,我们旨在基于机器学习方法,建立一种非体外循环冠状动脉旁路移植术后相关急性肾损伤(OPCABG-AKI)的预测模型:方法:回顾性收集2021年6月1日至2023年4月30日在天津大学附属胸科医院接受OPCABG手术的1041例患者的术前和术中数据。OPCABG-AKI的定义基于2012年肾脏疾病改善全球结局(KDIGO)标准。数据集包括基线数据和术中时间序列数据,并分别进行了预处理。根据基线数据共构建了八个机器学习模型:逻辑回归(LR)、梯度提升决策树(GBDT)、极梯度提升(XGBoost)、自适应提升(AdaBoost)、随机森林(RF)、支持向量机(SVM)、k-近邻(KNN)和决策树(DT)。术中时间序列数据使用长短期记忆(LSTM)深度学习模型提取。然后通过迁移学习整合基线数据和术中特征,并将其融合到八个机器学习模型中进行训练。在计算预测模型的准确率和曲线下面积(AUC)的基础上,选出最佳模型,建立最终的 OPCABG-AKI 风险预测模型。DT模型对特征的重要性进行了计算和排序,以确定主要的风险因素:结果:在纳入研究的 701 例患者中,73 例患者(10.4%)发生了 OPCABG-AKI。无论是仅基于基线数据(AUC =0.739,准确率:0.943)还是基于基线和术中数据集(AUC =0.861,准确率:0.936),GBDT 模型均显示出最佳预测效果。GBDT模型特征的重要性排序显示,使用阿斯巴甜胰岛素是预测OPCABG-AKI的最重要因素,其次是使用阿卡波糖、螺内酯、阿芬他尼、地佐辛、左西孟丹、克林霉素、心肌梗死病史和性别:基于 GBDT 的模型在预测 OPCABG-AKI 方面表现出色。融合术前和术中数据可提高预测 OPCABG-AKI 的准确性。
{"title":"Machine learning-based prediction of off-pump coronary artery bypass grafting-associated acute kidney injury.","authors":"Yuezi Song, Wenqian Zhai, Songnan Ma, Yubo Wu, Min Ren, Jef Van den Eynde, Paolo Nardi, Philip Y K Pang, Jason M Ali, Jiange Han, Zhigang Guo","doi":"10.21037/jtd-24-711","DOIUrl":"10.21037/jtd-24-711","url":null,"abstract":"<p><strong>Background: </strong>The cardiac surgery-associated acute kidney injury (CSA-AKI) occurs in up to 1 out of 3 patients. Off-pump coronary artery bypass grafting (OPCABG) is one of the major cardiac surgeries leading to CSA-AKI. Early identification and timely intervention are of clinical significance for CSA-AKI. In this study, we aimed to establish a prediction model of off-pump coronary artery bypass grafting-associated acute kidney injury (OPCABG-AKI) after surgery based on machine learning methods.</p><p><strong>Methods: </strong>The preoperative and intraoperative data of 1,041 patients who underwent OPCABG in Chest Hospital, Tianjin University from June 1, 2021 to April 30, 2023 were retrospectively collected. The definition of OPCABG-AKI was based on the 2012 Kidney Disease Improving Global Outcomes (KDIGO) criteria. The baseline data and intraoperative time series data were included in the dataset, which were preprocessed separately. A total of eight machine learning models were constructed based on the baseline data: logistic regression (LR), gradient-boosting decision tree (GBDT), eXtreme gradient boosting (XGBoost), adaptive boosting (AdaBoost), random forest (RF), support vector machine (SVM), k-nearest neighbor (KNN), and decision tree (DT). The intraoperative time series data were extracted using a long short-term memory (LSTM) deep learning model. The baseline data and intraoperative features were then integrated through transfer learning and fused into each of the eight machine learning models for training. Based on the calculation of accuracy and area under the curve (AUC) of the prediction model, the best model was selected to establish the final OPCABG-AKI risk prediction model. The importance of features was calculated and ranked by DT model, to identify the main risk factors.</p><p><strong>Results: </strong>Among 701 patients included in the study, 73 patients (10.4%) developed OPCABG-AKI. The GBDT model was shown to have the best predictions, both based on baseline data only (AUC =0.739, accuracy: 0.943) as well as based on baseline and intraoperative datasets (AUC =0.861, accuracy: 0.936). The ranking of importance of features of the GBDT model showed that use of insulin aspart was the most important predictor of OPCABG-AKI, followed by use of acarbose, spironolactone, alfentanil, dezocine, levosimendan, clindamycin, history of myocardial infarction, and gender.</p><p><strong>Conclusions: </strong>A GBDT-based model showed excellent performance for the prediction of OPCABG-AKI. The fusion of preoperative and intraoperative data can improve the accuracy of predicting OPCABG-AKI.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of thoracic disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1